HomeCirculationVol. 133, No. 14Further Evolution of the ACC/AHA Clinical Practice Guideline Recommendation Classification System Free AccessResearch ArticlePDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyRedditDiggEmail Jump toFree AccessResearch ArticlePDF/EPUBFurther Evolution of the ACC/AHA Clinical Practice Guideline Recommendation Classification SystemA Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines Jonathan L. Halperin, MD, FACC, FAHA, Chair, Glenn N. Levine, MD, FACC, FAHA, Chair-Elect, Sana M. Al-Khatib, MD, MHS, FACC, FAHA, Kim K. Birtcher, PHARMD, AACC, Biykem Bozkurt, MD, PHD, FACC, FAHA, Ralph G. Brindis, MD, MPH, MACC, Joaquin E. Cigarroa, MD, FACC, Lesley H. Curtis, PHD, FAHA, Lee A. Fleisher, MD, FACC, FAHA, Federico Gentile, MD, FACC, Samuel Gidding, MD, FAHA, Mark A. Hlatky, MD, FACC, John Ikonomidis, MD, PHD, FAHA, José Joglar, MD, FACC, FAHA, Susan J. Pressler, PHD, RN, FAHA and Duminda N. Wijeysundera, MD, PHD Jonathan L. HalperinJonathan L. Halperin , Glenn N. LevineGlenn N. Levine , Sana M. Al-KhatibSana M. Al-Khatib , Kim K. BirtcherKim K. Birtcher , Biykem BozkurtBiykem Bozkurt , Ralph G. BrindisRalph G. Brindis , Joaquin E. CigarroaJoaquin E. Cigarroa , Lesley H. CurtisLesley H. Curtis , Lee A. FleisherLee A. Fleisher , Federico GentileFederico Gentile , Samuel GiddingSamuel Gidding , Mark A. HlatkyMark A. Hlatky , John IkonomidisJohn Ikonomidis , José JoglarJosé Joglar , Susan J. PresslerSusan J. Pressler and Duminda N. WijeysunderaDuminda N. Wijeysundera Originally published23 Sep 2015https://doi.org/10.1161/CIR.0000000000000312Circulation. 2016;133:1426–1428Other version(s) of this articleYou are viewing the most recent version of this article. Previous versions: September 23, 2015: Previous Version 1 For 3 decades, the American College of Cardiology (ACC) and the American Heart Association (AHA) have jointly developed clinical practice guidelines in an effort to align patient care with scientific evidence.l The "2015 ACC/AHA/HRS Guideline on the Management of Patients With Supraventricular Tachycardia"2 introduces the latest recommendation classification system Table 1, which has continued to evolve. The present brief commentary summarizes and explains the changes incorporated in the current scheme. More detailed reviews of the evolution of ACC/AHA guideline methodology have been published.1,3-5Table 1. ACC/AHA Recommendation System: Applying Class of Recommendation and Level of Evidence to Clinical Strategies, Interventions, Treatments, or Diagnostic Testing in Patient Care* (Updated August 2015)Table 1. ACC/AHA Recommendation System: Applying Class of Recommendation and Level of Evidence to Clinical Strategies, Interventions, Treatments, or Diagnostic Testing in Patient Care* (Updated August 2015)Classes of Recommendation and Levels of EvidenceGuideline recommendations are categorized by the Class of Recommendation (COR) and Level of Evidence (LOE). The COR reflects the magnitude of benefit over risk and corresponds to the strength of the recommendation. Class I recommendations are strong and indicate that the treatment, procedure, or intervention is useful and effective and should be performed or administered for most patients under most circumstances. Class II recommendations are weaker, denoting a lower degree of benefit in proportion to risk. Benefit is generally greater for Class Ila (moderate) recommendations and smaller for Class lib (weak) recommendations, for which benefit only marginally exceeds risk. A COR of lib suggests that implementation should be selective and based on careful consideration of individual patient factors and, for invasive procedures, available expertise. Class III is assigned when actions are specifically not recommended, either because studies have found no evidence of benefit or because the intervention causes harm.The LOE denotes the confidence in or certainty of the evidence supporting the recommendation, based on the type, size, quality, and consistency of pertinent research findings. In general, for pharmacological treatments or therapeutic procedures, data from randomized controlled trials provide a higher LOE than do observational or retrospective studies, but other considerations apply to recommendations involving diagnostic testing, population-based interventions, or lifestyle modifications. High-quality, concordant evidence from more than 1 adequately powered randomized controlled trial, meta-analyses of high-quality trials, or randomized controlled trial data corroborated by high-quality registry or practice-based studies qualifies as LOE A. Moderate-quality or less convincing evidence based on 1 or more trials, meta-analyses of moderate-quality studies, or data derived exclusively from registries or other sources that have not been externally validated are assigned LOE B and are now further delineated according to whether the evidence derives from randomized (B-R) or nonrandomized studies (B-NR). When firm scientific support for a recommendation is not available, the evidence is designated as LOE C. There is now a new subcategorization of lower-quality evidence, assigned either because data are limited (C-LD) (ie, based on physiological preclinical studies, case reports, or studies with methodological deficiencies in design or execution) or because the recommendation is based on clinical experience and a consensus of expert opinion (C-EO).The COR and LOE are assessed independently. When a recommendation is designated as LOE C, that does not imply that the recommendation is weak. In some cases, clinical benefit is self-evident, and the intervention is unlikely to undergo randomized study. Where available data are weak, conflicting, or absent, recommendations based on this relatively low level of evidence may provide guidance for patient care when clinicians need it most.3 Nevertheless, because in the past a relatively high proportion of recommendations were based on LOE C and a modest percentage were based on LOE A,6 greater emphasis is now placed on formulating recommendations supported by higher-quality evidence and limiting those based on lower-quality evidence.Evolution in ContextThese modifications align with recommendations promulgated by the Institute of Medicine in 20117,8 and facilitate comparison of the strength (or COR) and quality (or LOE) with categories used by other guideline developers. The new scheme is intended mainly to increase the granularity and precision of the ACC/AHA system, while broadly retaining the COR and LOE categories familiar to readers of both US and European cardiovascular guidelines. The changes have been implemented as part of the continuous evolution of guideline development to ensure comprehensive, objective assessment of all available evidence and delivery of recommendations in a uniform format that is most useful at the point of care. Among the many remaining challenges are the development of more objective and standardized criteria for assessment of the quality of evidence, incorporation of cost and health economic methodology into guidelines, formulation of more efficient processes for revising and updating recommendations as new evidence emerges, and creation of tools to integrate context-sensitive guideline recommendations with electronic health records.3,9 The structured system for classifying the strength of clinical recommendations and quality of the evidence supporting them spans all of these ongoing initiatives and remains at the heart of the guidelines.Comprehensive disclosure information for the task force is available at http://www.acc.org/guidelines/about-guidelines-and-clinical-documents/guidelines-and-documents-task-forces.FootnotesThe ACC/AHA Recommendation System described in this document (Table 1) was approved by the American College of Cardiology Board of Trustees and Executive Committee and the American Heart Association Science Advisory and Coordinating Committee and Executive Committee in June 2015.The American Heart Association requests that this document be cited as follows: Halperin JL, Levine GN, Al-Khatib SM, Birtcher KK, Bozkurt B, Brindis RG, Cigarroa JE, Curtis LH, Fleisher LA, Gentile F, Gidding S, Hlatky MA, Ikonomidis J, Joglar J, Pressler SJ, Wijeysundera DN. Further evolution of the ACC/AHA clinical practice guideline recommendation classification system: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2016;133:1426-1428. DOI: 10.1161/CIR.0000000000000312.This article has been copublished in the Journal of the American College of Cardiology.Copies: This document is available on the World Wide Web sites of the American College of Cardiology (www.acc.org) and the American Heart Association (professional.heart.org). A copy of the document is available at http://professional.heart.org/statements by using either "Search for Guidelines & Statements" or the "Browse By Topic" area. To purchase additional reprints, call 843-216-2533 or e-mail [email protected].Expert peer review of AHA Scientific Statements is conducted by the AHA Office of Science Operations. For more on AHA statements and guidelines development, visit http://professional.heart.org/statements. Select the "Guidelines & Statements" drop-down menu, then click "Publication Development."Permissions: Multiple copies, modification, alteration, enhancement, and/or distribution of this document are not permitted without the express permission of the American Heart Association. Instructions for obtaining permission are located at http://www.heart.org/HEARTORG/General/Copyright-Permission-Guidelines_UCM_300404_Article.jsp. A link to the "Copyright Permissions Request Form" appears on the right side of the page.References1. Jacobs AK, Kushner FG, Ettinger SM, et al.. ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.Circulation. 2013; 127:268–310.LinkGoogle Scholar2. Page RL, Joglar JA, Al-Khatib SM, et al.. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.Circulation 2016; 133:e506–74.Google Scholar3. Jacobs AK, Anderson JL, Halperin JL. The evolution and future of ACC/AHA clinical practice guidelines: a 30-year journey: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.Circulation. 2014; 130:1208–17.LinkGoogle Scholar4. Gibbons RJ, Smith S, Antman E. American College of Cardiology/American Heart Association clinical practice guidelines: part I: where do they come from?Circulation. 2003: 107:2979–86.LinkGoogle Scholar5. Gibbons RJ, Smith SC, Antman E. American College of Cardiology/American Heart Association clinical practice guidelines: part II: evolutionary changes in a continuous quality improvement project.Circulation. 2003: 107:3101–7.LinkGoogle Scholar6. Tricoci P, Allen JM, Kramer JM, et al.. Scientific evidence underlying the ACC/AHA clinical practice guidelines.JAMA. 2009: 301:831–41.CrossrefMedlineGoogle Scholar7. Committee on Standards for Developing Trustworthy Clinical Practice Guidelines, Institute of Medicine (U.S.). Clinical Practice Guidelines We Can Trust. Washington, DC: National Academies Press: 2011.Google Scholar8. Committee on Standards for Systematic Reviews of Comparative Effectiveness Research, Institute of Medicine (U.S.). Finding What Works in Health Care: Standards for Systematic Reviews. Washington, DC: National Academies Press; 2011.Google Scholar9. Anderson JL, Heidenreich PA, Barnett PG, et al.. ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines.Circulation. 2014; 129:2329–45.LinkGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetailsCited ByLawton J, Tamis-Holland J, Bangalore S, Bates E, Beckie T, Bischoff J, Bittl J, Cohen M, DiMaio J, Don C, Fremes S, Gaudino M, Goldberger Z, Grant M, Jaswal J, Kurlansky P, Mehran R, Metkus T, Nnacheta L, Rao S, Sellke F, Sharma G, Yong C and Zwischenberger B (2021) 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines, Circulation, 145:3, (e18-e114), Online publication date: 18-Jan-2022. Kanukula R, Dhurjati R, Vidyasagar K, Rehana N, Talari A, Salam A, Rodgers A and Page M (2021) Quality of systematic reviews supporting the 2017 ACC/AHA and 2018 ESC/ESH guidelines for the management of hypertension, BMJ Evidence-Based Medicine, 10.1136/bmjebm-2021-111675, 27:2, (79-86), Online publication date: 1-Apr-2022. Palacio-Portilla E, Roquer J, Amaro S, Arenillas J, Ayo-Martín O, Castellanos M, Freijo M, Fuentes B, García-Pastor A, Gomis M, Gómez-Choco M, López-Cancio E, Martínez-Sánchez P, Morales A, Rodríguez-Yáñez M, Segura T, Serena J, Vivancos-Mora J and de Leciñana M (2022) Dislipidemias y prevención del ictus: recomendaciones del Grupo de Estudio de Enfermedades Cerebrovasculares de la Sociedad Española de Neurología, Neurología, 10.1016/j.nrl.2020.07.027, 37:1, (61-72), Online publication date: 1-Jan-2022. Tang Y, Sun M and Zhu A (2022) Outcome of cardiopulmonary resuscitation with different ventilation modes in adults: A meta-analysis, The American Journal of Emergency Medicine, 10.1016/j.ajem.2022.04.027, 57, (60-69), Online publication date: 1-Jul-2022. Palacio-Portilla E, Roquer J, Amaro S, Arenillas J, Ayo-Martín O, Castellanos M, Freijo M, Fuentes B, García-Pastor A, Gomis M, Gómez-Choco M, López-Cancio E, Martínez-Sánchez P, Morales A, Rodríguez-Yáñez M, Segura T, Serena J, Vivancos-Mora J and de Leciñana M (2022) Dyslipidemias and stroke prevention: Recommendations of the Study Group of Cerebrovascular Diseases of the Spanish Society of Neurology, Neurología (English Edition), 10.1016/j.nrleng.2020.07.021, 37:1, (61-72), Online publication date: 1-Jan-2022. Lukies M and Clements W (2022) Current Strategies for Prevention of Infection After Uterine Artery Embolisation, CardioVascular and Interventional Radiology, 10.1007/s00270-022-03158-3, 45:7, (911-917), Online publication date: 1-Jul-2022. Gill H, Nguyen P, Fay K, DelGaudio F, Roginski M, Atchinson P and Marcolini E (2022) Findings from a tandem clinician leadership intervention for emergency department cardiac arrest care during the COVID-19 pandemic, The American Journal of Emergency Medicine, 10.1016/j.ajem.2021.10.031, 51, (184-191), Online publication date: 1-Jan-2022. Heidenreich P, Bozkurt B, Aguilar D, Allen L, Byun J, Colvin M, Deswal A, Drazner M, Dunlay S, Evers L, Fang J, Fedson S, Fonarow G, Hayek S, Hernandez A, Khazanie P, Kittleson M, Lee C, Link M, Milano C, Nnacheta L, Sandhu A, Stevenson L, Vardeny O, Vest A and Yancy C (2022) 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines, Circulation, 145:18, (e895-e1032), Online publication date: 3-May-2022.Otto C, Nishimura R, Bonow R, Carabello B, Erwin J, Gentile F, Jneid H, Krieger E, Mack M, McLeod C, O'Gara P, Rigolin V, Sundt T, Thompson A and Toly C (2020) 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines, Circulation, 143:5, (e72-e227), Online publication date: 2-Feb-2021.Pavlović J, Greenland P, Franco O, Kavousi M, Ikram M, Deckers J, Ikram M and Leening M (2021) Recommendations and Associated Levels of Evidence for Statin Use in Primary Prevention of Cardiovascular Disease: A Comparison at Population Level of the American Heart Association/American College of Cardiology/Multisociety, US Preventive Services Task Force, Department of Veterans Affairs/Department of Defense, Canadian Cardiovascular Society, and European Society of Cardiology/European Atherosclerosis Society Clinical Practice Guidelines, Circulation: Cardiovascular Quality and Outcomes, 14:9, (e007183), Online publication date: 1-Sep-2021.Castonguay A, de Havenon A, Leslie‐Mazwi T, Kenmuir C, Sheth S, Asif K, Nguyen T, Janardhan V, Mansour O, Novakovic R, Hassan A, Liebeskind D, Czap A, Masoud H, Ma A, Nour M, Jadhav A, Malik A and Zaidat O (2022) Society of Vascular and Interventional Neurology Standards and Parameters for Guideline Development and Publication, Stroke: Vascular and Interventional Neurology, 1:1, Online publication date: 1-Nov-2021.Gulati M, Levy P, Mukherjee D, Amsterdam E, Bhatt D, Birtcher K, Blankstein R, Boyd J, Bullock-Palmer R, Conejo T, Diercks D, Gentile F, Greenwood J, Hess E, Hollenberg S, Jaber W, Jneid H, Joglar J, Morrow D, O'Connor R, Ross M and Shaw L (2021) 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines, Circulation, 144:22, (e368-e454), Online publication date: 30-Nov-2021. LeMaire S and Shen Y (2021) Commentary: Fluoroquinolones and Aortic Complications: Are We Ready for a Class III Recommendation With Level Z Evidence?, Seminars in Thoracic and Cardiovascular Surgery, 10.1053/j.semtcvs.2021.01.051, 33:4, (919-921), Online publication date: 1-Dec-2022. Pratama D and Rahmaditya F (2021) Screening Recommendations for Asymptomatic Carotid Artery Disease and Role of Carotid Intima-Media Thickness Evaluation: A Literature Review, Journal of Indonesian Society for Vascular and Endovascular Surgery, 10.36864/jinasvs.2021.1.010, 2:1, (34-40), Online publication date: 21-Jan-2021. Dessie G, Burrowes S, Mulugeta H, Haile D, Negess A, Jara D, Alem G, Tesfaye B, Zeleke H, Gualu T, Getaneh T, Kibret G, Amare D, Worku Mengesha E, Wagnew F and Khanam R (2021) Effect of a self-care educational intervention to improve self-care adherence among patients with chronic heart failure: a clustered randomized controlled trial in Northwest Ethiopia, BMC Cardiovascular Disorders, 10.1186/s12872-021-02170-8, 21:1, Online publication date: 1-Dec-2021. Fuller S, Kumar S, Roy N, Mahle W, Romano J, Nelson J, Hammel J, Imamura M, Zhang H, Fremes S, McHugh-Grant S, Nicolson S, Caldarone C, Chen J, Rosengart T, Fuller S, Kumar S and Emani S (2021) The American Association for Thoracic Surgery Congenital Cardiac Surgery Working Group 2021 consensus document on a comprehensive perioperative approach to enhanced recovery after pediatric cardiac surgery, The Journal of Thoracic and Cardiovascular Surgery, 10.1016/j.jtcvs.2021.04.072, 162:3, (931-954), Online publication date: 1-Sep-2021. Brignardello-Petersen R, Carrasco-Labra A and Guyatt G (2021) How to Interpret and Use a Clinical Practice Guideline or Recommendation, JAMA, 10.1001/jama.2021.15319, 326:15, (1516), Online publication date: 19-Oct-2021. Rodríguez-Yañez M, Gómez-Choco M, López-Cancio E, Amaro S, Alonso de Leciñana M, Arenillas J, Ayo-Martín O, Castellanos M, Freijo M, García-Pastor A, Gomis M, Martínez Sánchez P, Morales A, Palacio-Portilla E, Roquer J, Segura T, Serena J, Vivancos-Mora J and Fuentes B (2021) Prevención de ictus en pacientes con hipertensión arterial: recomendaciones del Grupo de Estudio de Enfermedades Cerebrovasculares de la Sociedad Española de Neurología, Neurología, 10.1016/j.nrl.2020.04.031, 36:6, (462-471), Online publication date: 1-Jul-2021. Orringer C, Blaha M, Blankstein R, Budoff M, Goldberg R, Gill E, Maki K, Mehta L and Jacobson T (2021) The National Lipid Association scientific statement on coronary artery calcium scoring to guide preventive strategies for ASCVD risk reduction, Journal of Clinical Lipidology, 10.1016/j.jacl.2020.12.005, 15:1, (33-60), Online publication date: 1-Jan-2021. Dimitriadis S, Qian E, Irvine A and Harky A (2021) Secondary Prevention Medications Post Coronary Artery Bypass Grafting Surgery—A Literature Review, Journal of Cardiovascular Pharmacology and Therapeutics, 10.1177/1074248420987445, 26:4, (310-320), Online publication date: 1-Jul-2021. Fuentes B, Amaro S, Alonso de Leciñana M, Arenillas J, Ayo-Martín O, Castellanos M, Freijo M, García-Pastor A, Gomis M, Gómez Choco M, López-Cancio E, Martínez Sánchez P, Morales A, Palacio-Portilla E, Rodríguez-Yáñez M, Roquer J, Segura T, Serena J and Vivancos-Mora J (2021) Prevención de ictus en pacientes con diabetes mellitus tipo 2 o prediabetes. Recomendaciones del Grupo de Estudio de Enfermedades Cerebrovasculares de la Sociedad Española de Neurología, Neurología, 10.1016/j.nrl.2020.04.030, 36:4, (305-323), Online publication date: 1-May-2021. Rodríguez-Yañez M, Gómez-Choco M, López-Cancio E, Amaro S, Alonso de Leciñana M, Arenillas J, Ayo-Martín O, Castellanos M, Freijo M, García-Pastor A, Gomis M, Martínez Sánchez P, Morales A, Palacio-Portilla E, Roquer J, Segura T, Serena J, Vivancos-Mora J and Fuentes B (2021) Stroke prevention in patients with arterial hypertension: Recommendations of the Spanish Society of Neurology's Stroke Study Group, Neurología (English Edition), 10.1016/j.nrleng.2020.04.023, 36:6, (462-471), Online publication date: 1-Jul-2021. Fuentes B, Amaro S, Alonso de Leciñana M, Arenillas J, Ayo-Martín O, Castellanos M, Freijo M, García-Pastor , Gomis M, Gómez Choco M, López-Cancio E, Martínez Sánchez P, Morales A, Palacio-Portilla E, Rodríguez-Yáñez M, Roquer J, Segura T, Serena J and Vivancos-Mora J (2021) Stroke prevention in patients with type 2 diabetes mellitus or prediabetes: recommendations of the Spanish Society of Neurology's Stroke Study Group, Neurología (English Edition), 10.1016/j.nrleng.2020.04.022, 36:4, (305-323), Online publication date: 1-May-2021. Malik A, Rocha R and Fremes S (2021) Commentary: Making decisions with all the evidence: What does the patient really want?, The Journal of Thoracic and Cardiovascular Surgery, 10.1016/j.jtcvs.2021.04.041, Online publication date: 1-Apr-2021. Malik S and Dineen E (2021) Integrative Approaches for Cardiovascular Disease Prevention ASPC Manual of Preventive Cardiology, 10.1007/978-3-030-56279-3_28, (705-732), . Bollag L, Lim G, Sultan P, Habib A, Landau R, Zakowski M, Tiouririne M, Bhambhani S and Carvalho B (2021) Society for Obstetric Anesthesia and Perinatology: Consensus Statement and Recommendations for Enhanced Recovery After Cesarean, Anesthesia & Analgesia, 10.1213/ANE.0000000000005257, 132:5, (1362-1377), Online publication date: 1-May-2021. Ommen S, Mital S, Burke M, Day S, Deswal A, Elliott P, Evanovich L, Hung J, Joglar J, Kantor P, Kimmelstiel C, Kittleson M, Link M, Maron M, Martinez M, Miyake C, Schaff H, Semsarian C and Sorajja P (2020) 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy, Circulation, 142:25, (e558-e631), Online publication date: 22-Dec-2020. Duff J, Topjian A, Berg M, Chan M, Haskell S, Joyner B, Lasa J, Ley S, Raymond T, Sutton R, Hazinski M and Atkins D (2020) 2019 American Heart Association Focused Update on Pediatric Advanced Life Support: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care, Pediatrics, 10.1542/peds.2019-1361, 145:1, Online publication date: 1-Jan-2020. Escobedo M, Aziz K, Kapadia V, Lee H, Niermeyer S, Schmölzer G, Szyld E, Weiner G, Wyckoff M, Yamada N and Zaichkin J (2020) 2019 American Heart Association Focused Update on Neonatal Resuscitation: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care, Pediatrics, 10.1542/peds.2019-1362, 145:1, Online publication date: 1-Jan-2020. Cronin E, Bogun F, Maury P, Peichl P, Chen M, Namboodiri N, Aguinaga L, Leite L, Al-Khatib S, Anter E, Berruezo A, Callans D, Chung M, Cuculich P, d'Avila A, Deal B, Della Bella P, Deneke T, Dickfeld T, Hadid C, Haqqani H, Kay G, Latchamsetty R, Marchlinski F, Miller J, Nogami A, Patel A, Pathak R, Saenz Morales L, Santangeli P, Sapp J, Sarkozy A, Soejima K, Stevenson W, Tedrow U, Tzou W, Varma N and Zeppenfeld K (2020) 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias: Executive summary, Heart Rhythm, 10.1016/j.hrthm.2019.03.014, 17:1, (e155-e205), Online publication date: 1-Jan-2020. Gallego-Colon E, Daum A and Yosefy C (2020) Statins and PCSK9 inhibitors: A new lipid-lowering therapy, European Journal of Pharmacology, 10.1016/j.ejphar.2020.173114, 878, (173114), Online publication date: 1-Jul-2020. Iqbal Z, Ho J, Adam S, France M, Syed A, Neely D, Rees A, Khatib R, Cegla J, Byrne C, Qureshi N, Capps N, Ferns G, Payne J, Schofield J, Nicholson K, Datta D, Pottle A, Halcox J, Krentz A, Durrington P and Soran H (2020) Managing hyperlipidaemia in patients with COVID-19 and during its pandemic: An expert panel position statement from HEART UK, Atherosclerosis, 10.1016/j.atherosclerosis.2020.09.008, 313, (126-136), Online publication date: 1-Nov-2020. Vlisides P, Moore L, Whalin M, Robicsek S, Gelb A, Lele A and Mashour G (2020) Perioperative Care of Patients at High Risk for Stroke During or After Non-cardiac, Non-neurological Surgery: 2020 Guidelines From the Society for Neuroscience in Anesthesiology and Critical Care, Journal of Neurosurgical Anesthesiology, 10.1097/ANA.0000000000000686, 32:3, (210-226), Online publication date: 1-Jul-2020. Duff J, Topjian A, Berg M, Chan M, Haskell S, Joyner B, Lasa J, Ley S, Raymond T, Sutton R, Hazinski M and Atkins D (2020) 2019 American Heart Association Focused Update on Pediatric Basic Life Support: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care, Pediatrics, 10.1542/peds.2019-1358, 145:1, Online publication date: 1-Jan-2020. Khan M, Irfan S, Khan S, Mehra M and Vaduganathan M (2020) Transforming the interpretation of significance in heart failure trials, European Journal of Heart Failure, 10.1002/ejhf.1668, 22:2, (177-180), Online publication date: 1-Feb-2020. Ghaffari S and Roshanravan N (2020) The role of nutraceuticals in prevention and treatment of hypertension: An updated review of the literature, Food Research International, 10.1016/j.foodres.2019.108749, 128, (108749), Online publication date: 1-Feb-2020. Cronin E, Bogun F, Maury P, Peichl P, Chen M, Namboodiri N, Aguinaga L, Leite L, Al-Khatib S, Anter E, Berruezo A, Callans D, Chung M, Cuculich P, d'Avila A, Deal B, Bella P, Deneke T, Dickfeld T, Hadid C, Haqqani H, Kay G, Latchamsetty R, Marchlinski F, Miller J, Nogami A, Patel A, Pathak R, Saenz Morales L, Santangeli P, Sapp J, Sarkozy A, Soejima K, Stevenson W, Tedrow U, Tzou W, Varma N and Zeppenfeld K (2020) 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias, Journal of Interventional Cardiac Electrophysiology, 10.1007/s10840-019-00663-3, 59:1, (145-298), Online publication date: 1-Oct-2020. Saver J and Hankey G (2020) Understanding Evidence Stroke Prevention and Treatment, 10.1017/9781316286234.003, (10-34) Kerneis M, Ferrante A, Guedeney P, Vicaut E and Montalescot G (2020) Severe acute respiratory syndrome coronavirus 2 and renin-angiotensin system blockers: A review and pooled analysis, Archives of Cardiovascular Diseases, 10.1016/j.acvd.2020.09.002, 113:12, (797-810), Online publication date: 1-Dec-2020. Cronin E, Bogun F, Maury P, Peichl P, Chen M, Namboodiri N, Aguinaga L, Leite L, Al-Khatib S, Anter E, Berruezo A, Callans D, Chung M, Cuculich P, d'Avila A, Deal B, Della Bella P, Deneke T, Dickfeld T, Hadid C, Haqqani H, Kay G, Latchamsetty R, Marchlinski F, Miller J, Nogami A, Patel A, Pathak R, Saenz Morales L, Santangeli P, Sapp J, Sarkozy A, Soejima K, Stevenson W, Tedrow U, Tzou W, Varma N and Zeppenfeld K (2020) 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias: Executive summary, Journal of Interventional Cardiac Electrophysiology, 10.1007/s10840-019-00664-2, 59:1, (81-133), Online publication date: 1-Oct-2020. Beneš V, Bradáč O, Horváth D, Suchomel P and Beneš V (2020) Surgery of acute occlusion of the extracranial internal carotid artery – a meta-analysis, Vasa, 10.1024/0301-1526/a000801, 49:1, (6-16), Online publication date: 1-Jan-2020. Cronin E, Bogun F, Maury P, Peichl P, Chen M, Namboodiri N, Aguinaga L, Leite L, Al-Khatib S, Anter E, Berruezo A, Callans D, Chung M, Cuculich P, d'Avila A, Deal B, Della Bella P, Deneke T, Dickfeld T, Hadid C, Haqqani H, Kay G, Latchamsetty R, Marchlinski F, Miller J, Nogami A, Patel A, Pathak R, Saenz Morales L, Santangeli P, Sapp J, Sarkozy A, Soejima K, Stevenson W, Tedrow U, Tzou W, Varma N and Zeppenfeld K (2020) 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias: executive summary, EP Europace, 10.1093/europace/euz332, 22:3, (450-495), Online publication date: 1-Mar-2020. Cronin E, Bogun F, Maury P, Peichl P, Chen M, Namboodiri N, Aguinaga L, Leite L, Al-Khatib S, Anter E, Berruezo A, Callans D, Chung M, Cuculich P, d'Avila A, Deal B, Della Bella P, Deneke T, Dickfeld T, Hadid C, Haqqani H, Kay G, Latchamsetty R, Marchlinski F, Miller J, Nogami A, Patel A, Pathak R, Saenz Morales L, Santangeli P, Sapp J, Sarkozy A, Soejima K, Stevenson W, Tedrow U, Tzou W, Varma N and Zeppenfeld K (20